Role of the GMP facility for adoptive immunotherapy

Cytotherapy. 2002;4(4):329-31. doi: 10.1080/146532402760271109.
No abstract available

MeSH terms

  • Accreditation*
  • Clinical Laboratory Techniques* / standards
  • Guidelines as Topic
  • Humans
  • Immunotherapy, Adoptive*
  • Research Personnel
  • United States
  • United States Food and Drug Administration